Multi-actor multi-criteria sustainability assessment framework for energy and industrial systems in life cycle perspective under uncertainties. Part 1: weighting method

Purpose

Life cycle sustainability assessment is meaningful for the decision-makers/stakeholders to select the most sustainable option among multiple alternatives; however, there are usually various severe uncertainty problems in sustainability-oriented decision-making, i.e., the vagueness and ambiguity that existed in human judgments and the lack of information. This study aims at developing a novel life cycle multi-criteria sustainability assessment method for helping the decision-makers/stakeholders to determine the sustainability level of the industrial and energy systems. In part 1, an improved interval analytic hierarchy process (AHP) which allows multiple decision-makers/stakeholders to participate in the decision-making was developed to determine the weights of the criteria which were used in life cycle sustainability assessment.

Methods

It is usually difficult for the decision-makers/stakeholders to use the numbers from 1 to 9 and their reciprocals for determining the comparison matrix when using the traditional AHP method for weight calculation, because human judgments usually involve various uncertainties. In order to the overcome this weak point of the traditional AHP, an improved AHP, so-called interval AHP, in which, multiple decision-makers/stakeholders are allowed to participate in the decision-making and allowed to use interval numbers instead of crisp numbers to establish the comparison matrix for determining the weights of the criteria for life cycle sustainability assessment, has been developed.

Results and discussion

The proposed method was used to determine the weights of the four aspects for life cycle sustainability assessment including economic, safety, social, and environmental aspects. Five representative stakeholders were invited to participate in the decision-making. After Monte Carlo simulation, the final weights of the four aspects have been determined with the proposed interval AHP.

Conclusions and perspectives

An interval AHP method was developed for determining the weights of the criteria for life cycle sustainability assessment; the decision-makers are allowed to use interval numbers to establish the comparison matrix for weight calculation. The weighting coefficients determined by Monte Carlo method can accurately reflect the preferences and willingness of multi-actor comparing with the traditional AHP method. This paper merely presents a novel method to calculate the weights of the criteria for life cycle sustainability assessment, but the method for determining the sustainability performance has been presented in part 2.

     

Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.

An avirulent, field-derived isolate of equine infectious anemia virus (EIAV), designated MA-1, was molecularly cloned, and the complete nucleotide sequence was determined for the 3' half of the viral genome. Comparisons between MA-1 and the prototype Wyoming strain of EIAV identified a 66-nucleotide stretch between CAAT (-91) and TATAA (-25) in the U3 region of the long terminal repeat, where sequence divergence was as high as 39.3%. The polymerase chain reaction was used to amplify and clone long terminal repeat sequences from Th-1, the in vivo parental stock of MA-1. Results indicated that the nucleotide sequences of MA-1 and Th-1 clones were less variable than was observed between MA-1 and Wyoming. However, MA-1 and Th-1 markedly differed in the types of enhancer sequences located in the hypervariable region. These results suggest that variation in lentivirus regulatory sequences may be important in EIAV host cell tropism and pathogenesis.     

10-Year Overview of the Hospital-Based Prevalence and Treatment of Congenital Cataracts: The CCPMOH Experience

A review of 6 years of hospitalization charts from Zhongshan Ophthalmic Center (ZOC) revealed that congenital cataracts (CC) accounted for 2.39% of all cataract in-patient cases and that the age at surgery was decreasing before the establishment of the Childhood Cataract Program of the Chinese Ministry of Health (CCPMOH) in December 2010. We aimed to investigate data from the 4 years (January 2011 to December 2014) following the establishment of the CCPMOH, compared, and combined with data from the previous study period (January 2005 to December 2010) to generate a 10-year overview of the hospital-based prevalence and treatment of CC. In the 4-year period after CCPMOH establishment, the prevalence of CC was 2.01% in all hospitalizations, and was 2.78% in all cataract in-patients. Most of the eligible CC in-patients (71%) lived in south China. The ratio of boys to girls was 1.42:1. Nearly 2/3 of the patients underwent cataract extraction with primary intraocular lens (IOL) implantation at a mean age of 78.40±51.45 months, and cataract extraction surgeries without IOL implantation were performed in the remaining 1/3 of patients at a mean age of 10.03±15.92 months. After CCPMOH establishment, an increased incidence of CC was revealed, and the CC in-patients were younger than the patients in the previous period. The 10-year overview (2421 CC in-patients from 206630 hospitalizations) revealed upward trends in both the number and the prevalence of CC and a further reduction in age at surgery. In conclusion, the data from 4-year period after CCPMOH establishment and the 10-year overview showed upward trends in the hospital-based prevalence of CC cases and a further reduction in age at surgery, likely reflecting the effects of the CCPMOH establishment and providing useful information for further CC studies and a valuable foundation for the prevention and treatment of this cause of childhood blindness.     

Long‐term administration of pyridostigmine attenuates pressure overload‐induced cardiac hypertrophy by inhibiting calcineurin signalling

Cardiac hypertrophy is associated with autonomic imbalance, characterized by enhanced sympathetic activity and withdrawal of parasympathetic control. Increased parasympathetic function improves ventricular performance. However, whether pyridostigmine, a reversible acetylcholinesterase inhibitor, can offset cardiac hypertrophy induced by pressure overload remains unclear. Hence, this study aimed to determine whether pyridostigmine can ameliorate pressure overload‐induced cardiac hypertrophy and identify the underlying mechanisms. Rats were subjected to either sham or constriction of abdominal aorta surgery and treated with or without pyridostigmine for 8 weeks. Vagal activity and cardiac function were determined using PowerLab. Cardiac hypertrophy was evaluated using various histological stains. Protein markers for cardiac hypertrophy were quantitated by Western blot and immunoprecipitation. Pressure overload resulted in a marked reduction in vagal discharge and a profound increase in cardiac hypertrophy index and cardiac dysfunction. Pyridostigmine increased the acetylcholine levels by inhibiting acetylcholinesterase in rats with pressure overload. Pyridostigmine significantly attenuated cardiac hypertrophy based on reduction in left ventricular weight/body weight, suppression of the levels of atrial natriuretic peptide, brain natriuretic peptide and β‐myosin heavy chain, and a reduction in cardiac fibrosis. These effects were accompanied by marked improvement of cardiac function. Additionally, pyridostigmine inhibited the CaN/NFAT3/GATA4 pathway and suppressed Orai1/STIM1 complex formation. In conclusion, pressure overload resulted in cardiac hypertrophy, cardiac dysfunction and a significant reduction in vagal discharge. Pyridostigmine attenuated cardiac hypertrophy and improved cardiac function, which was related to improved cholinergic transmission efficiency (decreased acetylcholinesterase and increased acetylcholine), inhibition of the CaN/NFAT3/GATA4 pathway and suppression of the interaction of Orai1/STIM1.     

不同营林面积情景下鹿科动物的潜在生境分布

在有人为干扰的森林景观中开展鹿科动物适宜生境分布研究,对于解决大尺度生境保护与小面积森林经营的矛盾问题有着重要的参考意义,也符合我国林区的现实需求.2013—2015年冬季进行的多次野外调查收集196处鹿科动物出现点信息,将这些点作为分布点数据,选取地形、景观类型、植被特征和人类干扰4类17种因子作为环境变量,利用最大熵模型方法,分析4种林下经营面积情景下小兴安岭铁力林业局马鹿和狍的潜在适宜生境分布特征及其对环境因子的响应.结果表明:模型预测精度达到优秀水平,稳定性好,鹿科动物的适宜生境主要集中在东部区域;不同情景下,两种鹿科动物的主要环境影响因子相似,均为距农田距离、距居民点距离、距河流距离、距营林区距离和海拔因子,其中,距营林区距离因子的贡献率稳定在4%～6%;两种鹿科动物躲避人类经营活动干扰的距离(1200～1300 m)较为接近.在无林下经营情景中,鹿科动物的适宜生境分布较广、面积较大;随着经营面积的增大,适宜生境面积减少;当经营面积扩大到现实情况的2～3倍时,鹿科动物栖息地面积缩减较为严重.     

Determination of 8-oxoguanine in human plasma and urine by high-performance liquid chromatography with electrochemical detection

A highly sensitive and selective method for determining 8-oxoguanine in plasma and urine was developed by high-performance liquid chromatography with electrochemical detection. The compound was separated by gradient elution on a C₁₈ reversed-phase column with a mobile phase of acetonitrile and 0.1 M sodium acetate, pH 5.2. 8-Hydroxy-2′-deoxyguanosine was used as internal standard. 8-Oxoguanine was detected electrochemically by setting the potential to +300 mV vs. Pd reference. The sensitivity of the assay was 22 ng/ml with a signal-to-noise ratio of 7:1. The within-day relative standard deviations for 8-oxoguanine quality control samples with concentrations of 3340, 1340 and 84 ng/ml were 3.6, 4.3 and 5.7% for plasma, and 4.1, 4.6 and 6.2% for urine, respectively. The day-to-day relative standard deviations for the same samples were 3.8, 6.8 and 7.1% for plasma, and 3.9, 7.0 and 7.9% for urine, respectively. The method is designed to study the pharmacokinetics and metabolic fate of O⁶-benzylguanine in a phase I clinical trial. Previously, O⁶-benzyl-8-oxoguanine was identified as the primary metabolite of O⁶-benzylguanine in humans. We now demonstrate that 8-oxoguanine is a further metabolite of O⁶-benzylguanine.